Jovi Cheng is an associate in the Hong Kong office of Latham & Watkins and a member of the Corporate Department.

Ms. Cheng advises clients on a variety of corporate and commercial transactions, including capital markets in particular, initial public offerings, placing, M&A, and general compliance matters of Hong Kong-listed companies.

Ms. Cheng’s recent representative experience includes advising:

  • Tianqi Lithium, a leading global lithium producer, on its HK$13.5 billion (US$1.7 billion) H share initial public offering on the Main Board of The Stock Exchange of Hong Kong Limited
  • Zai Lab Limited in its US$766 million secondary listing and initial public offering in Hong Kong*
  • Pop Mart International Group Limited in its HK$5.2 billion initial public offering in Hong Kong*
  • Hangzhou Tigermed Consulting Co., Ltd. in its HK$10.7 billion initial public offering in Hong Kong*
  • Antengene Corporation Limited in its HK$2.79 billion initial public offering in Hong Kong*
  • Morgan Stanley Asia Limited, Huatai Financial Holdings (Hong Kong) Limited and J.P. Morgan Securities (Far East) Limited as the underwriters’ counsel in respect of the HK$4 billion initial public offering of RemeGen Co., Ltd. In Hong Kong*
  • Ming Yuan Cloud Group Holdings Limited in its HK$6.2 billion initial public offering in Hong Kong*
  • Venus Medtech (Hangzhou) Inc. in its placing of HK$1.2 billion new H shares in Hong Kong*

*Matter handled prior to joining Latham

Bar Qualification

  • Hong Kong (Solicitor)
  • New York

Education

  • PCLL, City University of Hong Kong, 2019
  • LLB, London School of Economics and Political Science, 2018

Languages Spoken

  • English

Practices